The Human Growth Hormone Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market for human growth hormone expanded swiftly in the past few years. In terms of market size, it was worth $4.75 billion in 2024 and is projected to increase to $5.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.1%.
The Human Growth Hormone market is predicted to reach $7.6 billion by 2029, expanding at a compound annual growth rate (CAGR) of 9.8%.
Download Your Free Sample of the 2025 Human Growth Hormone Market Report and Uncover Key Trends Now!The drivers in the human growth hormone market are:
• Increasing occurrence of growth disorders
• Rising awareness about hormone therapies
• Broadening applications in sports medicine
• Growing numbers of the elderly population
• Enhanced healthcare infrastructure
The human growth hormone market covered in this report is segmented –
1) By Product: Liquid, Powder
2) By Brand: Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Others Brands
3) By Route Of Administration: Oral, Intravenous, Intramuscular, Subcutaneous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Specialty Pharmacy
5) By Application: Growth Hormone (GH) Deficiency, Adult Growth Hormone (GH) Deficiency, Pediatric Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Other Applications
The trends in the human growth hormone market are:
• Personalized medicine is a rising trend influencing the human growth hormone market.
• The utilization of recombinant DNA technology greatly impacts the market.
• There is an increasing trend towards sustainable manufacturing processes.
• The development of long-acting formulations and combination therapies are emerging trends in the market.
The major players in the human growth hormone market are:
• Pfizer Inc.
North America was the largest region in the human growth hormone market in 2024